- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Alkermes Completes Avadel Deal, Expands Sleep Medicine Market Reach
Feb 13, 2026
Rx Green Technologies Launches New Clean Coco Coir Products
May 05, 2020
AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate
Jul 15, 2020
Innovation Disrupting the Pricing of Drugs in Healthcare Industry
Jan 23, 2020
Small Cell Lung Cancer (SCLC) Treatment Market is expected to reach US$ 9,173.60 million by 2030
Dec 21, 2023
Asia Pacific Pharmaceutical Drug Delivery Market is anticipated to grow during 2019-2027 with a CAGR value of 7.1%
Aug 04, 2020
Malaria and Sickle Cell Disease Treatment Market is expected to reach US$ 29,179.60 million by 2030
Nov 03, 2023